Rare diseases
Investigational molecules
Locations
700 King Farm Boulevard, 20850-5736, United States
Ascentage Pharma Group Inc. focuses on blood cancers including acute myeloid leukemia, chronic lymphocytic leukemia, small lymphocytic lymphoma, chronic myeloid leukemia, and Philadelphia chromosome-positive acute lymphoblastic leukemia. Its clinical work also extends to myelodysplastic syndrome, with attention to both newly diagnosed and relapsed or refractory disease settings.
The sponsor’s portfolio includes therapies for both frontline and previously treated haematologic cancers, with a strong concentration on lymphoid malignancies and myeloid neoplasms.
Ascentage Pharma Group Inc. runs clinical trials in conditions such as Chronic lymphocytic leukaemia, B-cell small lymphocytic lymphoma, Acute lymphocytic leukaemia, Philadelphia positive acute lymphocytic leukaemia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Bulgaria
Italy
BelgiumBelgium
HungaryBelgiumBulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
